Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company, has been added to the Russell 3000® and Russell 2000® indexes ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE